Showing results (191-200 of 365) with videos related to
Sort By:
Pageof 37
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force ReportS Gauthier, A Boxer, D Knopman, et al.The Journal of Nutrition, Health & Aging|February 28, 2018
Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary CareL Rouch, F Farbos, C Cool, et al.The Journal of Nutrition, Health & Aging|May 5, 2012
End-of-life care for persons with advanced Alzheimer disease: design and baseline data from the ALFINE studyF Nourhashémi, S Gillette, C Cantet, et al.La Revue De Medecine Interne|January 9, 2004
[Wandering and Alzheimer's type disease. Descriptive study. REAL.FR research program on Alzheimer's disease and management]Y Rolland, S Gillette-Guyonnet, F Nourhashémi, et al.The Journal of Nutrition, Health & Aging|August 11, 2000
Determination of appendicular muscle mass by dual energy X-ray absorptiometry method in women with sarcopenia and Alzheimer's diseaseS Gillette-Guyonnet, F Nourhashemi, S Andrieu, et al.The Journal of Nutrition, Health & Aging|May 31, 2011
Sarcopenia: designing phase IIB trialsWm C Chumlea, M Cesari, W J Evans, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 22, 2006
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's DiseaseF Portet, P J Ousset, P J Visser, et al.The Journal of Nutrition, Health & Aging|April 30, 2015
Validation of the Mini Nutritional Assessment-Short Form in a Population of Frail Elders without Disability. Analysis of the Toulouse Frailty Platform Population in 2013M Lilamand, E Kelaiditi, M Cesari, et al.Neurology|August 25, 2004
Economic evaluation of donepezil in moderate to severe Alzheimer diseaseH Feldman, S Gauthier, J Hecker, et al.The Journal of Prevention of Alzheimer'S Disease|June 8, 2021
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task ForceP S Aisen, R J Bateman, M Carrillo, et al.Pageof 37